• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical Efficacy and Safety of Omalizumab in the Treatment of Allergic Rhinitis: A Systematic Review and Meta-analysis of Randomized Clinical Trials.

作者信息

Yu Chenjie, Wang Kaijian, Cui Xinyan, Lu Ling, Dong Jianfei, Wang Maohua, Gao Xia

机构信息

Department of Otorhinolaryngology, Affiliated Drum Tower Hospital of Nanjing University Medical School, Jiangsu Provincial Key Medical Discipline, Nanjing, The People's Republic of China.

Department of Otorhinolaryngology, Drum Tower Clinical Medical College, Nanjing Medical University, Nanjing, The People's Republic of China.

出版信息

Am J Rhinol Allergy. 2020 Mar;34(2):196-208. doi: 10.1177/1945892419884774. Epub 2019 Nov 1.

DOI:10.1177/1945892419884774
PMID:31672020
Abstract
摘要

相似文献

1
Clinical Efficacy and Safety of Omalizumab in the Treatment of Allergic Rhinitis: A Systematic Review and Meta-analysis of Randomized Clinical Trials.奥马珠单抗治疗过敏性鼻炎的临床疗效与安全性：随机临床试验的系统评价与荟萃分析
Am J Rhinol Allergy. 2020 Mar;34(2):196-208. doi: 10.1177/1945892419884774. Epub 2019 Nov 1.
2
Omalizumab for the treatment of inadequately controlled allergic rhinitis: a systematic review and meta-analysis of randomized clinical trials.奥马珠单抗治疗控制不佳的过敏性鼻炎：随机临床试验的系统评价和荟萃分析。
J Allergy Clin Immunol Pract. 2014 May-Jun;2(3):332-40.e1. doi: 10.1016/j.jaip.2014.02.001.
3
[Safety and efficacy of omalizumab for the treatment of allergic rhinitis:Meta-analysis of randomized clinical trials].奥马珠单抗治疗变应性鼻炎的安全性和有效性：随机临床试验的Meta分析
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 May 5;30(9):694-698. doi: 10.13201/j.issn.1001-1781.2016.09.006.
4
Anti-IgE treatment in allergic rhinitis.过敏性鼻炎的抗IgE治疗。
Int J Pediatr Otorhinolaryngol. 2019 Dec;127:109674. doi: 10.1016/j.ijporl.2019.109674. Epub 2019 Sep 10.
5
The use of anti-IgE therapy beyond allergic asthma.抗IgE疗法在过敏性哮喘之外的应用。
J Allergy Clin Immunol Pract. 2015 Mar-Apr;3(2):162-6. doi: 10.1016/j.jaip.2014.10.010. Epub 2015 Jan 16.
6
Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.抗IgE疗法用于治疗囊性纤维化患者的过敏性支气管肺曲霉病。
Cochrane Database Syst Rev. 2015 Nov 4(11):CD010288. doi: 10.1002/14651858.CD010288.pub3.
7
IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy.变应性哮喘中 IgE 介导的多种共病及奥马珠单抗治疗的潜力。
J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1418-1429. doi: 10.1016/j.jaip.2019.02.030. Epub 2019 Mar 27.
8
The use of omalizumab in allergen immunotherapy.奥马珠单抗在变应原免疫治疗中的应用。
Clin Exp Allergy. 2018 Mar;48(3):232-240. doi: 10.1111/cea.13084. Epub 2018 Jan 30.
9
Efficacy of omalizumab in patients with atopic dermatitis: A systematic review and meta-analysis.奥马珠单抗治疗特应性皮炎患者的疗效：一项系统评价和荟萃分析。
J Allergy Clin Immunol. 2016 Dec;138(6):1719-1722.e1. doi: 10.1016/j.jaci.2016.05.038. Epub 2016 Jul 14.
10
Effectiveness and safety of omalizumab in patients with allergic bronchopulmonary aspergillosis with or without allergic rhinitis: a retrospective chart review.奥马珠单抗治疗变应性支气管肺曲霉病伴或不伴变应性鼻炎患者的有效性和安全性：一项回顾性图表分析。
BMC Pulm Med. 2023 Oct 13;23(1):389. doi: 10.1186/s12890-023-02696-x.

引用本文的文献

1
Recent Studies and Prospects of Biologics in Allergic Rhinitis Treatment.生物制剂在过敏性鼻炎治疗中的最新研究与前景
Int J Mol Sci. 2025 May 9;26(10):4509. doi: 10.3390/ijms26104509.
2
Bibliometric and visual analysis of drug-specific immunotherapy from 1990 to 2024.1990年至2024年药物特异性免疫疗法的文献计量学与可视化分析
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 25. doi: 10.1007/s00210-025-04073-3.
3
Allergies to Allergens from Cats and Dogs: A Review and Update on Sources, Pathogenesis, and Strategies.对猫和狗过敏原的过敏反应：来源、发病机制和策略的综述和更新。
Int J Mol Sci. 2024 Sep 29;25(19):10520. doi: 10.3390/ijms251910520.
4
V Brazilian Consensus on Rhinitis - 2024.第五届巴西鼻炎共识 - 2024年
Braz J Otorhinolaryngol. 2025 Jan-Feb;91(1):101500. doi: 10.1016/j.bjorl.2024.101500. Epub 2024 Sep 7.
5
Allergic rhinitis as a predictor of moderate-to-severe paediatric obstructive sleep apnoea.变应性鼻炎是儿童中-重度阻塞性睡眠呼吸暂停的预测因子。
Sleep Breath. 2024 Jun;28(3):1303-1310. doi: 10.1007/s11325-024-03011-6. Epub 2024 Feb 28.
6
Unanswered questions on the use of biologics in pediatric asthma.关于生物制剂在儿童哮喘治疗中应用的未解决问题。
World Allergy Organ J. 2023 Nov 3;16(11):100837. doi: 10.1016/j.waojou.2023.100837. eCollection 2023 Nov.
7
Adverse Events for Monoclonal Antibodies in Patients with Allergic Rhinitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.变应性鼻炎患者使用单克隆抗体的不良事件：一项随机临床试验的系统评价和荟萃分析
J Clin Med. 2023 Apr 13;12(8):2848. doi: 10.3390/jcm12082848.
8
B Lineage Cells and IgE in Allergic Rhinitis and CRSwNP and the Role of Omalizumab Treatment.B 谱系细胞和 IgE 在变应性鼻炎和 CRSwNP 中的作用及奥马珠单抗治疗的作用。
Am J Rhinol Allergy. 2023 Mar;37(2):182-192. doi: 10.1177/19458924221147770.
9
Epidemiology, Prevention and Clinical Treatment of Allergic Rhinitis: More Understanding, Better Patient Care.变应性鼻炎的流行病学、预防与临床治疗：深入了解，优化患者护理。
J Clin Med. 2022 Oct 14;11(20):6062. doi: 10.3390/jcm11206062.
10
Current and Future Approaches in Management of Chronic Spontaneous Urticaria Using Anti-IgE Antibodies.目前和未来使用抗 IgE 抗体治疗慢性自发性荨麻疹的方法。
Medicina (Kaunas). 2022 Jun 17;58(6):816. doi: 10.3390/medicina58060816.